SI
IPXL

Stephens Inc’s Impax Laboratories, Inc. IPXL Stock Holding History

Stephens Inc’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-16,774
Closed -$591K – 804
2015
Q3 		$591K Sell
16,774
-21,500
-56% -$969K 0.03% 416
2015
Q2 		$1.76M Buy
38,274
+11,570
+43% +$549K 0.08% 261
2015
Q1 		$1.25M Buy
+26,704
New +$1.06M 0.06% 319

Other funds holding IPXL

HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AG
Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Stephens Inc's IPXL Position: Q4 2015 in Review

Stephens Inc sold out of Impax Laboratories, Inc. (IPXL) in Q4 2015, closing a stake of 16,774 shares — an estimated $591K sold.

Stephens Inc first reported a position in IPXL in Q1 2015 and held it in 3 quarters. The position peaked at $1.76M in Q2 2015. 196 funds tracked by Wall St. Rank hold IPXL as of Q4 2015.

  • Stephens Inc reported no remaining Impax Laboratories, Inc. position as of Q4 2015 after selling out during the quarter.
  • Stephens Inc sold 16,774 Impax Laboratories, Inc. shares in Q4 2015, an estimated $591K.
  • Stephens Inc first reported a position in Impax Laboratories, Inc. in Q1 2015 and held it in 3 quarters.
  • Stephens Inc's Impax Laboratories, Inc. position peaked at $1.76M in Q2 2015.
  • 196 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2015.

Based on Stephens Inc's 13F filing for Q4 2015, filed 10 Feb 2016.